DENTSPLY SIRONA Inc
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
XRAY$9.54+0.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
(in millions, except per share amounts)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Net sales | $953 | $978 |
| Cost of products sold | 447 | 459 |
| Gross profit | 506 | 519 |
| Selling, general, and administrative expenses | 415 | 416 |
| Research and development expenses | 42 | 46 |
| Intangible asset impairments | 6 | — |
| Restructuring and other costs | 1 | 59 |
| Operating income (loss) | 42 | (2) |
| Other income and expenses: | ||
| Interest expense, net | 18 | 20 |
| Other (income) expense, net | (7) | 6 |
| Income (loss) before income taxes | 31 | (28) |
| Provision (benefit) for income taxes | 14 | (5) |
| Net income (loss) | 17 | (23) |
| Less: Net loss attributable to noncontrolling interest | (1) | (4) |
| Net income (loss) attributable to Dentsply Sirona | $18 | $(19) |
| Net income (loss) per common share attributable to Dentsply Sirona: | ||
| Basic | $0.09 | $(0.09) |
| Diluted | $0.09 | $(0.09) |
| Weighted average common shares outstanding: | ||
| Basic | 207.4 | 214.5 |
| Diluted | 208.5 | 214.5 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.